Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

NGR-based peptides as molecular imaging agents of neovascularization after myocardial infarction

Geert Hendrikx, Tilman Hackeng, Rick van Gorp, Matthias Bauwens, Leon Schurgers, Felix Mottaghy, Mark Post and Ingrid Dijkgraaf
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 914;
Geert Hendrikx
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tilman Hackeng
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rick van Gorp
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Bauwens
2Maastricht University Medical Center Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon Schurgers
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Mottaghy
2Maastricht University Medical Center Maastricht Netherlands
3Universitatsklinikum Aachen Aachen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Post
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Dijkgraaf
1Maastricht University Maastricht Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

914

Objectives: Angiogenesis plays an important role in restoration of blood perfusion after myocardial infarction (MI). The receptor CD13 is selectively expressed on angiogenic endothelium and binds the tripeptide motif Asn-Gly-Arg (NGR). Aim of this study was to design and synthesize cyclic Asn-Gly-Arg (NGR)-based imaging probes with improved stability and efficacy for non-invasive SPECT imaging of angiogenesis.

Methods: Linear CNGRG-MpaL thioester peptide was synthesized by manual Boc-based solid-phase peptide synthesis and cyclized using native chemical ligation instead of disulfide bridging. This monomeric cyclic backbone coNGR peptide contained a sulfhydryl group that was conjugated to maleimide-DTPA. Additional to this monomer, a tetrameric coNGR peptide was synthesized by coupling coNGR to a tetrameric scaffold containing a thiaproline (Thz) at the core. The sulfhydryl group of Thz was decrypted and reacted with maleimide-DTPA. Resulting DTPA-[SMCC-coNGR]4 and its monomeric counterpart DTPA-coNGR were radiolabeled with 111InCl3. Angiogenesis after MI was visualized in combination with 99mTc-sestamibi in dual-isotope micro-SPECT imaging in a mouse model of MI. CD13 immunohistochemistry was performed to validate co-localization of coNGR peptide uptake with CD13 expression. Blood stability was examined using HPLC and biodistribution patterns were evaluated.

Results: In vitro studies indicated better stability for both novel imaging agents after 50 min blood incubation compared to the previously reported disulfide-cyclized cNGR imaging agent. Uptake patterns of 111In-labeled mono- and tetrameric coNGR peptides coincided with CD13 immunohistochemistry on excised hearts. In addition, tetrameric coNGR showed a significantly higher specific uptake in infarcted myocardium compared to monomeric coNGR imaging agent. Dual-isotope SPECT allowed simultaneous imaging of CD13-positive angiogenic endothelium and perfusion in the border zone of infarcted myocardium.

Conclusion: Backbone-cyclized angiogenesis SPECT agents, mono- and tetrameric coNGR demonstrated a markedly higher stability in blood compared to disulfide-cyclized cNGR. Radiolabeled tetrameric coNGR is a promising sensitive imaging agent for detection of angiogenesis in infarcted myocardium. Research Support: This study was performed within the framework of the Center for Translational Molecular Medicine, project EMINENCE (grant 01C-204 to GH; TH; MP; ID), the Weijerhorst Foundation (MB; FM) and The Netherlands Organisation for Scientific Research (NWO; VIDI 723.013.009 to ID).

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
NGR-based peptides as molecular imaging agents of neovascularization after myocardial infarction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
NGR-based peptides as molecular imaging agents of neovascularization after myocardial infarction
Geert Hendrikx, Tilman Hackeng, Rick van Gorp, Matthias Bauwens, Leon Schurgers, Felix Mottaghy, Mark Post, Ingrid Dijkgraaf
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 914;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
NGR-based peptides as molecular imaging agents of neovascularization after myocardial infarction
Geert Hendrikx, Tilman Hackeng, Rick van Gorp, Matthias Bauwens, Leon Schurgers, Felix Mottaghy, Mark Post, Ingrid Dijkgraaf
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 914;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Cardiovascular, Endocrine & Other Posters

  • Radiosynthesis of b-phenylethylamine derivatives for cardiac sympathetic nervous PET imaging
  • Feasibility and potentials of thymidine phosphorylase (TP) as an imaging biomarker and its nuclear medicine imaging for the diagnosis of non-alcoholic steatohepatitis
  • Synthesis and characterization of an 18F-labeled AmBF3-conjugated albumin-binding peptide for imaging blood pool by PET/CT
Show more Preclinical Probes for Cardiovascular, Endocrine & Other Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire